Production and characterization of exopolysaccharides from Pseudomonas aeruginosa AG01 with some medical potential applications

There is growing interest in the production and characterization of bacterial exopolysaccharides (EPS) because of their diverse range of applications. This study aimed to examine the production of EPS by Pseudomonas aeruginosa AG01, to characterize the produced EPS and its application as antioxidant, antimicrobial, antibiofilm, antitumor, and antiviral activity. The results indicated that the ideal conditions for achieving the highest production of EPS included an incubation period of 96 h, a pH level of 6, and a temperature of 32 °C in a nutrient broth medium. The most efficient sources of carbon and nitrogen for the formation of EPS were found to be galactose, glucose, yeast extract, and peptone. Several functional groups were confirmed to be present by Fourier transform infrared spectroscopy including amino groups, amides, carboxylic acids, hydroxyl groups, and phosphates. In the same respect, EPS has antioxidant activity. Moreover, EPS produced by Pseudomonas aeruginosa AG01 demonstrated antibacterial activity against various Gram-positive, Gram-negative bacteria, and yeast, besides antibiofilm activity about 98.93%, 98.86%, 98.63%, and 97.19% for Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli, respectively as well as anticancer activity against prostate cancer (PC3) and breast cancer (MCF7) cells with IC50 values of 156.41 and 156.41 µg/ml, respectively. Flow cytometry analysis revealed that MCF7 cells treated with EPS at a concentration of 500 µg/ml for 48 h showed a reduction in the percentage of cells in both the G0/G1 and S phases compared to the untreated control MCF7 cells. EPS resulted in apoptosis induction in MCF7 cells using the Annexin V-FITC PI staining method. The findings indicate that EPS demonstrates significant antiviral activity against both the herpes simplex virus (HSV-1) and the hepatitis A virus (HAV). In conclusion, EPS has great potential to be developed as a natural antioxidant or used in medicine and pharmaceuticals.

Authors

Institutions

Publication Details

Journal
Microbial Cell Factories
Published
2025-05-14
DOI
https://doi.org/10.1186/s12934-025-02730-z
Citations
10
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
11.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Production and characterization of exopolysaccharides from Pseudomonas aeruginosa AG01 with some medical potential applications

Abeer E. El-Ansary, Heba Ibrahim Mohamed, Amira Mohamed Ghanaim
10 citations
Microbial Cell Factories
Probiotics and Fermented Foods
11.62
article

Production and characterization of exopolysaccharides from Pseudomonas aeruginosa AG01 with some medical potential applications

Abeer E. El-Ansary, Heba Ibrahim Mohamed, Amira Mohamed Ghanaim
article en
10 citations

Abstract

There is growing interest in the production and characterization of bacterial exopolysaccharides (EPS) because of their diverse range of applications. This study aimed to examine the production of EPS by Pseudomonas aeruginosa AG01, to characterize the produced EPS and its application as antioxidant, antimicrobial, antibiofilm, antitumor, and antiviral activity. The results indicated that the ideal conditions for achieving the highest production of EPS included an incubation period of 96 h, a pH level of 6, and a temperature of 32 °C in a nutrient broth medium. The most efficient sources of carbon and nitrogen for the formation of EPS were found to be galactose, glucose, yeast extract, and peptone. Several functional groups were confirmed to be present by Fourier transform infrared spectroscopy including amino groups, amides, carboxylic acids, hydroxyl groups, and phosphates. In the same respect, EPS has antioxidant activity. Moreover, EPS produced by Pseudomonas aeruginosa AG01 demonstrated antibacterial activity against various Gram-positive, Gram-negative bacteria, and yeast, besides antibiofilm activity about 98.93%, 98.86%, 98.63%, and 97.19% for Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli, respectively as well as anticancer activity against prostate cancer (PC3) and breast cancer (MCF7) cells with IC50 values of 156.41 and 156.41 µg/ml, respectively. Flow cytometry analysis revealed that MCF7 cells treated with EPS at a concentration of 500 µg/ml for 48 h showed a reduction in the percentage of cells in both the G0/G1 and S phases compared to the untreated control MCF7 cells. EPS resulted in apoptosis induction in MCF7 cells using the Annexin V-FITC PI staining method. The findings indicate that EPS demonstrates significant antiviral activity against both the herpes simplex virus (HSV-1) and the hepatitis A virus (HAV). In conclusion, EPS has great potential to be developed as a natural antioxidant or used in medicine and pharmaceuticals.

Microbial Cell FactoriesVol. 24(1)
Ain Shams University (EG), Cairo University (EG)
Ain Shams University
Openalex Percentile: Top 1%
Probiotics and Fermented Foods
11.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.